Daniel Rudeklint
Algemeen Directeur bij EMOTRA AB (PUBL)
Profiel
Mr. Daniel Rudeklint, CPA, is a President, Chief Executive Officer, CFO & Director at Emotra AB and a Chief Financial Officer & Director at Peptonic Medical AB.
He is on the Board of Directors at KebNi AB, Emotra AB and Peptonic Medical AB.
He received his graduate degree from Luleå University of Technology.
Actieve functies van Daniel Rudeklint
| Bedrijven | Functie | Begin |
|---|---|---|
| EMOTRA AB (PUBL) | Algemeen Directeur | 01-11-2021 |
| PEPTONIC MEDICAL AB | Financieel Directeur/CFO | 15-05-2024 |
| KEBNI AB | Directeur/Bestuurslid | 01-06-2022 |
Opleiding van Daniel Rudeklint
| Luleå University of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PEPTONIC MEDICAL AB | Health Technology |
| KEBNI AB | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Emotra AB
 Emotra AB Medical SpecialtiesHealth Technology Emotra AB engages in the research and development of physiological and statistical methods for psychiatric care. It offers a medical device that tests the psychophysiological being of patients suffering from depression through their responses to sound signals. The company was founded by Elizabeth Kaminski and Lars-Håkan Thorell on June 18, 2001 and is headquartered in Molndal, Sweden. | Health Technology |
